5-fluorodopa has been researched along with levodopa in 7 studies
| Studies (5-fluorodopa) | Trials (5-fluorodopa) | Recent Studies (post-2010) (5-fluorodopa) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 32 | 1 | 5 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | 5-fluorodopa (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björklund, A; Brundin, P; Gustavii, B; Langston, JW; Lindvall, O; Rehncrona, S; Snow, B; Tetrud, J; Widner, H | 1 |
| Argentini, M; Cogoli-Greuter, M; Mäder, T; Weinreich, R; Wiese, C; Winterhalter, KH | 1 |
| Cogoli-Greuter, M; Weinreich, R; Wiese, C; Winterhalter, KH | 1 |
| Clark, JC; Firnau, G; Garnett, ES; Jones, T; Leenders, KL; Marsden, CD; Nahmias, C; Palmer, AJ; Quinn, N | 1 |
| Martin, WR | 1 |
| Lang, AE | 1 |
| Abbs, JH; Bendlin, BB; Brooks, BR; Brown, WD; Chung, MK; Dejesus, OT; Dogan, S; Gallagher, CL; Holden, JE; Johnson, SC; Konopacki, RA; Nickles, RJ; Oakes, TR; Pyzalski, RW; Xu, G | 1 |
2 review(s) available for 5-fluorodopa and levodopa
| Article | Year |
|---|---|
Positron emission tomography in movement disorders.
Topics: Brain; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dystonia; Glucose; Humans; Huntington Disease; Levodopa; Movement Disorders; Oxygen Consumption; Parkinson Disease; Synapses; Tomography, Emission-Computed | 1985 |
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed | 1995 |
1 trial(s) available for 5-fluorodopa and levodopa
| Article | Year |
|---|---|
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fetal Tissue Transplantation; Humans; Immunosuppression Therapy; Levodopa; Male; Mesencephalon; Motor Activity; Parkinson Disease, Secondary; Putamen; Stereotaxic Techniques; Time Factors; Tomography, Emission-Computed | 1992 |
4 other study(ies) available for 5-fluorodopa and levodopa
| Article | Year |
|---|---|
Metabolism of 5-fluoro-dopa and 6-fluoro-dopa enantiomers in aggregating cell cultures of fetal rat brain.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Cells, Cultured; Dihydroxyphenylalanine; Female; Fetus; Levodopa; Rats; Rats, Inbred Strains; Stereoisomerism; Time Factors | 1992 |
Comparative metabolism of fluorinated 3,4-dihydroxyphenylalanine isomers in aggregating brain cell cultures.
Topics: Animals; Brain; Cell Aggregation; Cells, Cultured; Decarboxylation; Dihydroxyphenylalanine; Levodopa; Methylation; Stereoisomerism | 1992 |
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
Topics: Adult; Aged; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1986 |
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease.
Topics: Aged; Aging; Antiparkinson Agents; Carbidopa; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Female; Hand Strength; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Muscle Strength; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Psychomotor Performance; Radiopharmaceuticals; Reaction Time; Retrospective Studies; Sex Characteristics; Tongue | 2011 |